Viewing Study NCT07170293


Ignite Creation Date: 2025-12-25 @ 1:06 AM
Ignite Modification Date: 2025-12-25 @ 11:18 PM
Study NCT ID: NCT07170293
Status: RECRUITING
Last Update Posted: 2025-09-12
First Post: 2025-09-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors
Sponsor: Tianjin Medical University Second Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module